114 related articles for article (PubMed ID: 16350427)
1. Neuropathic pain and balance problems are poorly evaluated in patients receiving taxane-based chemotherapy.
J Support Oncol; 2005; 3(6):412. PubMed ID: 16350427
[No Abstract] [Full Text] [Related]
2. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy.
Wampler MA; Topp KS; Miaskowski C; Byl NN; Rugo HS; Hamel K
Arch Phys Med Rehabil; 2007 Aug; 88(8):1002-8. PubMed ID: 17678662
[TBL] [Abstract][Full Text] [Related]
3. Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy.
Kneis S; Wehrle A; Freyler K; Lehmann K; Rudolphi B; Hildenbrand B; Bartsch HH; Bertz H; Gollhofer A; Ritzmann R
Clin Neurophysiol; 2016 Feb; 127(2):1481-1490. PubMed ID: 26350407
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.
Dunlap B; Paice JA
J Support Oncol; 2006 Sep; 4(8):398-9. PubMed ID: 17004514
[No Abstract] [Full Text] [Related]
5. Referred symptom from myofascial pain syndrome: One of the most important causes of sensory disturbance in breast cancer patients using taxanes.
Ko EJ; Jeon JY; Kim W; Hong JY; Yi YG
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28004441
[TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain associated with non-surgical treatment of breast cancer.
Jung BF; Herrmann D; Griggs J; Oaklander AL; Dworkin RH
Pain; 2005 Nov; 118(1-2):10-4. PubMed ID: 16213086
[No Abstract] [Full Text] [Related]
7. Invited commentary.
Campbell KL; McNeely ML
Phys Ther; 2010 Nov; 90(11):1657-9; author reply 1659. PubMed ID: 21041184
[No Abstract] [Full Text] [Related]
8. Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
Wampler MA; Hamolsky D; Hamel K; Melisko M; Topp KS
Clin J Oncol Nurs; 2005 Apr; 9(2):189-93. PubMed ID: 15853162
[TBL] [Abstract][Full Text] [Related]
9. GM1 for taxane-induced neuropathy in breast cancer.
Das M
Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
[No Abstract] [Full Text] [Related]
10. Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.
Monfort SM; Pan X; Patrick R; Singaravelu J; Loprinzi CL; Lustberg MB; Chaudhari AMW
Gait Posture; 2016 Jul; 48():237-242. PubMed ID: 27341530
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of taxane neuropathy.
Kudlowitz D; Muggia F
Anticancer Drugs; 2014 May; 25(5):495-501. PubMed ID: 24300917
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of lysophosphatidic acid receptor 1 are associated with the onset of taxane-induced peripheral neuropathy.
Tsuchida R; Tanabe Y; Nishizawa D; Ikeda K; Abe H; Inoue R; Kurano M; Yatomi Y; Tamura K; Takano T; Shimizu C; Uchida K; Sumitani M
Br J Anaesth; 2021 Aug; 127(2):e43-e46. PubMed ID: 34024637
[No Abstract] [Full Text] [Related]
14. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH
Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520
[TBL] [Abstract][Full Text] [Related]
15. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
Kautio AL; Haanpää M; Leminen A; Kalso E; Kautiainen H; Saarto T
Anticancer Res; 2009 Jul; 29(7):2601-6. PubMed ID: 19596934
[TBL] [Abstract][Full Text] [Related]
16. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
Fontes F; Pereira S; Castro-Lopes JM; Lunet N
Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
[TBL] [Abstract][Full Text] [Related]
17. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
Andersen Hammond E; Pitz M; Shay B
Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
[TBL] [Abstract][Full Text] [Related]
19. Current methods for the assessment and management of taxane-related neuropathy.
Smith EM
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid induced peripheral neuropathy.
Mahashur AA
J Assoc Physicians India; 1992 Oct; 40(10):651-2. PubMed ID: 1344033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
